v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 1,228,789 $ 547,890
Investments held in marketable securities 7,884,132 10,184,701
Accounts receivable 25,000 188,400
Prepaid expenses and other current assets 217,400 223,230
Total Current Assets 9,355,321 11,144,221
Deferred offering costs 148,697
Property and equipment, net 369,992 362,936
Intangible assets, net 601,508 623,945
Total Assets 10,326,821 12,279,799
Current Liabilities:    
Accounts payable 599,500 483,070
Accrued expenses and other current liabilities 277,610 744,485
Deferred revenue 150,000
Warrant liabilities 3,154,970 2,520,851
Total Current Liabilities 4,182,080 3,748,406
Total Liabilities 4,182,080 3,748,406
Commitments and contingencies  
Stockholders’ Equity:    
Preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 1,398,158 shares issued and outstanding at March 31, 2025 and December 31, 2024 13,982 13,982
Common stock, $0.0001 par value; 75,000,000 shares authorized; 7,504,780 and 6,919,919 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 750 692
Additional paid-in capital 167,148,523 164,195,434
Accumulated deficit (161,018,514) (155,678,715)
Total Stockholders’ Equity 6,144,741 8,531,393
Total Liabilities and Stockholders’ Equity $ 10,326,821 $ 12,279,799

Source

10-Q XBRL Zip